Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-29

Clinical Trial Update: Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating amifostine added to standard idarubicin and cytarabine therapy in older adults with acute myeloid leukemia; the Phase 1/2 study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amifostine (amifostine)
  • CYTARABINE (CYTARABINE)
  • Idarubicin (idarubicin)

Snippet

Sponsor: MedImmune LLC | Conditions: Leukemia, Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED